20 / 158
20
LISI 2016 FINANCIAL REPORT
1.3
I
LISI MEDICAL
€119.1 million
SALES REVENUE
8% of consolidated
sales revenue
915
STAFF
8% of Group headcount
€5.6 million
CAPEX
4% of total Group CAPEX
Activity
Medical implant and auxiliary
parts subcontractor
Flagship products
Joint reconstruction:
orthopedic reconstruction
implants and instruments
(hip, shoulder, knee).
Spine, extremities,
trauma and dental:
orthopedic implants
and instruments, trauma
and extremities, spine,
maxillofacial and dental.
Mini-invasive single-use
instruments:
vascular, gastro intestinal,
urology.
Customers
Alphatech;
Ace Surgical;
Boston Scientific;
C2F Implants;
Integra Lifescience;
Intuitive Surgical;
Johnson & Johnson and
subsidiaries;
Medacta;
Medicrea;
Medtronic;
Signature Orthopaedics;
Smith & Nephew;
Spineway;
Stryker;
Zimmer-Biomet;
Wright Tornier.
Competitors
Accelent;
CoorsTek;
Greatbach;
Marle;
Norwood;
Orchid/Sandvik;
Paragon;
Tecomet;
SFS Tegra.
2
6
6
5
4
4
8
5
9
7
3
1
10
9
MINI-INVASIVE SURGERY INSTRUMENTS (MIS)
10
VASCULAR IMPLANTS
INSTRUMENTS
3
TRAUMATOLOGY
IMPLANTS
5
UPPER EXTREMETIES IMPLANTS
7
TOTAL HIP PROSTHESIS
2
MAXILLOFACIAL
IMPLANTS
4
LOWER EXTREMETIES
IMPLANTS
6
SPINAL IMPLANTS
1
DENTAL
IMPLANTS
8
TOTAL KNEE PROSTHESIS
FINANCIAL SITuaTION
2